| Ultrasound-mediated delivery of paclitaxel for glioma: a comparative study of distribution, toxicity, and efficacy of albumin-bound versus cremophor formulations DY Zhang, C Dmello, L Chen, VA Arrieta, E Gonzalez-Buendia, JR Kane, ... Clinical cancer research 26 (2), 477-486, 2020 | 152 | 2020 |
| CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments MP Jogalekar, RL Rajendran, F Khan, C Dmello, P Gangadaran, BC Ahn Frontiers in immunology 13, 925985, 2022 | 136 | 2022 |
| Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment VA Arrieta, C Dmello, DJ McGrail, DJ Brat, C Lee-Chang, AB Heimberger, ... The Journal of Clinical Investigation 133 (2), 2023 | 127 | 2023 |
| Tumor microenvironment signaling and therapeutics in cancer progression A Goenka, F Khan, B Verma, P Sinha, CC Dmello, MP Jogalekar, ... Cancer Communications 43 (5), 525-561, 2023 | 119 | 2023 |
| STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma P Zhang, A Rashidi, J Zhao, C Silvers, H Wang, B Castro, A Ellingwood, ... Nature communications 14 (1), 1610, 2023 | 94 | 2023 |
| ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma VA Arrieta, AX Chen, JR Kane, SJ Kang, C Kassab, C Dmello, J Zhao, ... Nature cancer 2 (12), 1372-1386, 2021 | 80 | 2021 |
| Multifaceted role of keratins in epithelial cell differentiation and transformation C Dmello, SS Srivastava, R Tiwari, PR Chaudhari, S Sawant, MM Vaidya Journal of biosciences 44, 1-16, 2019 | 61 | 2019 |
| Clinical significance of aberrant vimentin expression in oral premalignant lesions and carcinomas SS Sawant, MM Vaidya, DA Chaukar, H Alam, C Dmello, P Gangadaran, ... Oral diseases 20 (5), 453-465, 2014 | 61 | 2014 |
| Vimentin regulates differentiation switch via modulation of keratin 14 levels and their expression together correlates with poor prognosis in oral cancer patients C Dmello, S Sawant, H Alam, P Gangadaran, S Mogre, R Tiwari, ... PLoS One 12 (2), e0172559, 2017 | 52 | 2017 |
| Vimentin-mediated regulation of cell motility through modulation of beta4 integrin protein levels in oral tumor derived cells C Dmello, S Sawant, H Alam, P Gangadaran, R Tiwari, H Dongre, N Rana, ... The international journal of biochemistry & cell biology 70, 161-172, 2016 | 40 | 2016 |
| CD8+ T-cell–Mediated Immunoediting Influences Genomic Evolution and Immune Evasion in Murine Gliomas JR Kane, J Zhao, T Tsujiuchi, B Laffleur, VA Arrieta, A Mahajan, G Rao, ... Clinical Cancer Research 26 (16), 4390-4401, 2020 | 36 | 2020 |
| Utility of keratins as biomarkers for human oral precancer and cancer M Vaidya, C Dmello, S Mogre Life 12 (3), 343, 2022 | 30 | 2022 |
| Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas VA Arrieta, A Gould, KS Kim, KJ Habashy, C Dmello, ... Nature Communications 15 (1), 4698, 2024 | 19 | 2024 |
| Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth Cell Metab, 2023 | 19* | 2023 |
| Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade C Dmello, J Zhao, L Chen, A Gould, B Castro, VA Arrieta, DY Zhang, ... Nature communications 14 (1), 1566, 2023 | 19 | 2023 |
| Aberrant expression of vimentin predisposes oral premalignant lesion derived cells towards transformation C Dmello, S Sawant, PR Chaudhari, H Dongre, C Ahire, ZC D'Souza, ... Experimental and Molecular Pathology 105 (3), 243-251, 2018 | 16 | 2018 |
| FKBP1A upregulation correlates with poor prognosis and increased metastatic potential of HNSCC D Patel, AM Dabhi, C Dmello, M Seervi, KM Sneha, P Agrawal, ... Cell Biology International 46 (3), 443-453, 2022 | 14 | 2022 |
| Biomarker potential of vimentin in oral cancers S Mogre, V Makani, S Pradhan, P Devre, S More, M Vaidya, C Dmello Life 12 (2), 150, 2022 | 12 | 2022 |
| Ultrasound-mediated blood–brain barrier opening increases cell-free DNA in a time-dependent manner DY Zhang, A Gould, HC Happ, MW Youngblood, C Dmello, SJ Kang, ... Neuro-Oncology Advances 3 (1), vdab165, 2021 | 12 | 2021 |
| ERK1/2 phosphorylation predicts survival in recurrent glioblastoma following intracerebral and adjuvant PD-1/CTLA-4 immunotherapy: A REMARK-guided analysis VA Arrieta, J Duerinck, KB Burdett, KJ Habashy, W Geens, A Gould, ... Clinical Cancer Research 30 (2), 379-388, 2024 | 11 | 2024 |